Pilulka Lekarny as (PINK) — Capital Reinvestment Ratio

Latest as of December 2021: 3.33x

Pilulka Lekarny as (PINK) has a Capital Reinvestment Ratio of 3.33x as of December 2021, meaning it reinvests 3% of its operating cash flow (Kč24.67 Million) in capital expenditures (Kč82.13 Million). Check Pilulka Lekarny as tangible book value ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

3.33x
Capex / Operating Cash Flow

Operating Cash Flow

Kč24.67 Million
CZK

Capital Expenditures

Kč82.13 Million
CZK

Data as of

Dec 2021
Most recent filing

Pilulka Lekarny as Capital Reinvestment Ratio (2020–2021)

This chart tracks Pilulka Lekarny as's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see PINK cash flow conversion.

Annual Capital Reinvestment Ratio for Pilulka Lekarny as (2020–2021)

Year-by-year Capital Reinvestment Ratio for Pilulka Lekarny as from 2020 to 2021. See Pilulka Lekarny as free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CZK) Capital Expenditures YoY Change
2021 3.33x Kč24.67 Million Kč82.13 Million ▼ -11.0%
2020 3.74x Kč7.39 Million Kč27.65 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow